COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,285 Articles (22,759 medRxiv, 8,526 bioRxiv)

Most recent first Previous |  Page 2013: Articles 20121-20130  | Next

Molecular basis of the logical evolution of the novel coronavirus SARS-CoV-2: A comparative analysis
Dwivedy, A., Murmu, K., Ahmad, M., Prasad, P., Biswal, B., Aich, P.
10.1101/2020.12.03.409458 — Posted: 2020-12-03
Horizontal gene transfer and recombination analysis of SARS-CoV-2 genes helps discover its close relatives and shed light on its origin
Makarenkov, V., Mazoure, B., Rabusseau, G., Legendre, P.
10.1101/2020.12.03.410233 — Posted: 2020-12-03
In Vitro Analysis of the Anti-viral Potential of nasal spray constituents against SARS-CoV-2
Cannon, M. L., Westover, J. B., Bleher, R., Sanchez-Gonzalez, M. A., Ferrer, G.
10.1101/2020.12.02.408575 — Posted: 2020-12-03 Discussion: Onsite
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker, T., Darling, T., Hassan, A., Harastani, H., Soung, A., Jiang, X., Dai, Y.-N., Zhao, H., Adams, L., Holtzman, M., Bailey, A., Case, J. B., Fremont, D., Klein, R. S., Diamond, M., Boon, A.
10.1101/2020.12.02.408823 — Posted: 2020-12-03 Discussion: Onsite
The impact of non-pharmaceutical interventions on the prevention and control of COVID-19 in New York City
Yang, J., Zhang, Q., cao, z., gao, J., Pfeiffer, D., Zhong, L., Zeng, D. D.
10.1101/2020.12.01.20242347 — Posted: 2020-12-03
Large parallel screen of saliva and nasopharyngeal swabs in a test center setting proofs utility of saliva as alternate specimen for SARS-CoV-2 detection by RT-PCR
Huber, M., Schreiber, P. W., Scheier, T., Audige, A., Buonomano, R., Rudiger, A., Braun, D. L., Eich, G., Keller, D., Hasse, B., Berger, C., Manrique, A., Guenthard, H. F., Boeni, J., Trkola, A.
10.1101/2020.12.01.20241778 — Posted: 2020-12-03
A Novel Model for Simulating COVID-19 Dynamics Through Layered Infection States that Integrate Concepts from Epidemiology, Biophysics and Medicine: SEI3R2S-Nrec
Winters, J. M.
10.1101/2020.12.01.20242263 — Posted: 2020-12-03
How effective are face coverings in reducing transmission of COVID-19?
Robinson, J. F., Rios de Anda, I., Moore, F. J., Gregson, F. K. A., Reid, J. P., Husain, L., Sear, R. P., Royall, C. P.
10.1101/2020.12.01.20241992 — Posted: 2020-12-03
Impact of social distancing regulations and epidemic risk perception on social contact and SARS-CoV-2 transmission potential in rural South Africa: analysis of repeated cross-sectional surveys
McCreesh, N., Dlamini, V., Edwards, A., Olivier, S., Dayi, N., Dikgale, K., Nxumalo, S., Dreyer, J., Baisley, K., Siedner, M., White, R. G., Herbst, K., Grant, A., Harling, G.
10.1101/2020.12.01.20241877 — Posted: 2020-12-03
Associations between vaping and Covid-19: cross-sectional findings from the HEBECO study
Kale, D., Herbec, A., Perski, O., Jackson, S. E., Brown, J., Shahab, L.
10.1101/2020.12.01.20241760 — Posted: 2020-12-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).